Home Cart Sign in  
Chemical Structure| 131189-57-6 Chemical Structure| 131189-57-6

Structure of Cornuside
CAS No.: 131189-57-6

Chemical Structure| 131189-57-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cornuside, a natural product isolated and purified from the fruits of Cornus officinalis Sieb.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cornuside

CAS No. :131189-57-6
Formula : C24H30O14
M.W : 542.49
SMILES Code : O=C(C1=CO[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@H](C=C)[C@@H]1CCOC(C3=CC(O)=C(O)C(O)=C3)=O)OC
MDL No. :MFCD21606970

Safety of Cornuside

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Cornuside

MAPK
pyroptosis
TLR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human umbilical vein endothelial cells (HUVECs) 1, 2, 5, 10, or 20 μM 16 h CN inhibited LPS-induced HMGB1 release and reduced the expression of HMGB1 receptor proteins (TLR2, TLR4, and RAGE). Int J Mol Sci. 2022 Feb 13;23(4):2065
C6 cells 10 µM 24 h Cornuside regulates MCM-induced A1/A2 phenotypic switch of C6 cells via AKT/Nrf2/NF-κB pathway Nutrients. 2022 Aug 3;14(15):3179
Bone mesenchymal stem cells 10, 30, 60 μM Cornuside I significantly promoted BMSC proliferation, with the optimal dose being 30 μM. Cornuside I dose-dependently increased ALP activity and calcium deposition, and significantly upregulated the expression of RUNX2, OSX, and OCN. J Orthop Surg Res. 2021 Jun 21;16(1):397
BV2 cells 10 and 30 µM 24 h Cornuside inhibited NLRP3 inflammasome activation and subsequent cytokine release, also protected neurons from damaging factors in microenvironment of conditional culture. Alzheimers Res Ther. 2025 Feb 19;17(1):47

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Male Balb/c mice PM2.5-induced lung injury model Tail vein injection 0.2, 0.4, 0.6, 0.8 mg/kg Single dose, evaluated after 24 hours To evaluate the protective effects of Cornuside on PM2.5-induced lung injury, results showed that Cornuside reduced pulmonary edema, inflammatory cell infiltration, and inflammatory cytokine levels, and alleviated lung injury by inhibiting TLR4-MyD88 and mTOR-autophagy pathways. Int J Mol Sci. 2023 Mar 4;24(5):4979
Male C57BL/6 mice Cecal ligation and puncture (CLP)-induced sepsis model Intravenous injection 0.08, 0.2, 0.4, or 0.8 mg/kg Injected at 12 h and 50 h after CLP surgery, lasting for 132 h CN significantly improved the survival rate of CLP-induced septic mice, alleviated lung tissue pathological damage, and reduced the levels of liver and kidney injury markers (ALT, AST, BUN, creatinine, and LDH). Int J Mol Sci. 2022 Feb 13;23(4):2065
3×Tg-AD mice Alzheimer's disease model Intraperitoneal injection 10 mg/kg and 20 mg/kg Once daily for 4 weeks Cornuside significantly ameliorated cognitive deficits, reduced amyloid plaque pathology, inhibited Tau phosphorylation, repaired synaptic damage, and modulated astrocyte A1/A2 phenotypes in 3×Tg-AD mice Nutrients. 2022 Aug 3;14(15):3179
Lewis rats Experimental autoimmune encephalomyelitis (EAE) model Gavage 150 mg/kg Once daily for two weeks Cornuside can alleviate symptoms of EAE neurological deficits through its anti-inflammatory and immunosuppressive effects, and Th17 cells may be one of its therapeutic targets. J Zhejiang Univ Sci B. 2021 May 15;22(5):421-430
ICR mice Aβ1−42-induced Alzheimer's disease model Intragastric administration 3, 10, 30 mg/kg Once daily for 2 weeks Cornuside significantly ameliorated behavioral deficits, protected synaptic plasticity and relieved neuronal damage in Aβ1?42 induced mice, and decreased NLRP3 inflammasome activation. Alzheimers Res Ther. 2025 Feb 19;17(1):47

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.84mL

0.37mL

0.18mL

9.22mL

1.84mL

0.92mL

18.43mL

3.69mL

1.84mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories